Monopar Therapeutics (MNPR) has the highest short interest by a US stock in the Biotechnology Industry, with 54.16% of float sold short (1.355M shares).
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
Monopar Therapeutics (MNPR) | 1.3553M | 4.5302M | 54.16% | 4.06 |
Pasithea Therapeutics (KTTA) | 264,669 | 5.9241M | 51.85% | .21 |
Kalvista Pharmaceuticals (KALV) | 20.0621M | 27.1666M | 44.66% | 15.62 |
Intellia Therapeutics (NTLA) | 45.3196M | 110.0198M | 43.89% | 6.96 |
Immunitybio (IBRX) | 135.1609M | 336.4936M | 40.85% | 2.79 |
LENZ Therapeutics (LENZ) | 7.2608M | 20.0521M | 39.96% | 6.01 |
Tango Therapeutics (TNGX) | 45.822M | 85.2612M | 39.45% | 14.1 |
AnaptysBio (ANAB) | 5.6647M | 15.8666M | 38.83% | 11.67 |
Sana Biotechnology (SANA) | 36.8859M | 176.9576M | 37.76% | 14.61 |
Arcturus Therapeutics (ARCT) | 6.8821M | 26.2733M | 36.56% | 13.62 |
Tectonic Therapeutic (TECX) | 3.7687M | 12.1199M | 35.43% | 16.29 |
ARS Pharmaceuticals (SPRY) | 21.3992M | 105.4062M | 35.27% | 12.05 |
Recursion Pharmaceuticals (RXRX) | 165.5487M | 504.1027M | 33.69% | 8.17 |
Replimune (REPL) | 15.3377M | 56.9759M | 33.29% | 10.79 |
Purple Biotech (PPBT) | 125,042 | 508.6304M | 31.66% | .16 |
Novavax (NVAX) | 51.1816M | 140.1992M | 31.61% | 8.37 |
Rezolute (RZLT) | 18.9764M | 66.7386M | 31.42% | 4.29 |
Summit Therapeutics (SMMT) | 36.9647M | 125.1631M | 31.21% | 12.11 |
Organogenesis (ORGO) | 13.0377M | 55.8997M | 29.86% | 16.3 |
Immunocore (IMCR) | 10.931M | 37.7189M | 29.77% | 21.67 |
Absci (ABSI) | 37.2586M | 132.6427M | 29.13% | 10.33 |
Neurogene (NGNE) | 3.591M | 5.2101M | 28.81% | 23.37 |
Iovance Biotherapeutics (IOVA) | 105.255M | 338.6533M | 28.61% | 8.36 |
Abeona Therapeutics (ABEO) | 14.3346M | 39.9536M | 28.2% | 11.47 |
Viking Therapeutics (VKTX) | 26.0612M | 112.6677M | 27.63% | 7.79 |
Historical short interest data is not available.
